UBS AM
IDIX

UBS AM’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

UBS AM’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-36,496
Closed -$880K – 2607
2014
Q2 		$880K Sell
36,496
-12,000
-25% -$125K ﹤0.01% 1619
2014
Q1 		$292K Hold
48,496
– – ﹤0.01% 2195
2013
Q4 		$290K Buy
48,496
+1,600
+3% +$7.4K ﹤0.01% 2162
2013
Q3 		$244K Hold
46,896
– – ﹤0.01% 2215
2013
Q2 		$169K Buy
+46,896
New +$192K ﹤0.01% 2309

UBS AM's IDIX Position: Q3 2014 in Review

UBS AM sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 36,496 shares — an estimated $880K sold.

UBS AM first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $880K in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • UBS AM reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • UBS AM sold 36,496 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $880K.
  • UBS AM first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • UBS AM's IDENIX PHARMACEUTICALS INC position peaked at $880K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on UBS AM's 13F filing for Q3 2014, filed 28 Oct 2014.